Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Genetic Association Studies × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 1

Interventions

Cyclophosphamide 19 fludarabine phosphate 13 Cyclosporine 12 Whole-Body Irradiation 11 Mycophenolic Acid 10 Antilymphocyte Serum 10 Peripheral Blood Stem Cell Transplantation 9 Busulfan 8 Filgrastim 7 fludarabine 6 Melphalan 6 Radiotherapy 5 Therapeutics 4 Psychiatric Rehabilitation 4 Methotrexate 4 Cytarabine 4 Cord Blood Stem Cell Transplantation 4 Blood Specimen Collection 4 thymoglobulin 3 Stem Cell Transplantation 3 Palliative Care 3 Methylprednisolone 3 Granulocyte Colony-Stimulating Factor 3 Dexamethasone 3 Behavior Therapy 3 sargramostim 2 Voriconazole 2 Thiotepa 2 Tacrolimus 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06886425 2025-03-20

CDA-AML-MDS

Assistance Publique Hopitaux De Marseille

Phase NA Recruiting

Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡